Health
Pfizer aims for $15bn in 2021 COVID-19 vaccine sales – PMLiVE
Current estimate is based on already agreed contracts
Pfizer has forecast major sales expectations for its BioNTech-partnered COVID-19 vaccine, BNT162b2, in its fourth quarter results – aiming for approximately $15bn in revenues for 2021.
The company said that the 2021 guidance for the vaccine mainly includes doses that are expected to be delivered in the year under existing contracts, adding that it may be adjusted dependent on future additional contracts.
In the fourth quarter of 2020 alone BNT162b2 contributed $154m to Pfizer’s overall sales.
For…
-
Noosa News12 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business23 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News21 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General13 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle